ScienceNot yet confirmed elsewhere1 publisher3 min readPublished
A nematode's pheromone primes plant defense genes by loosening their chromatin
Boyce Thompson Institute researchers report that ascaroside 18 leaves defense genes easier to switch on, and that field sprays cut fungal disease in corn and soybean. Three of the four named leads co-founded the startup behind it.
The Scientist · Science desk

What happened
- A Communications Biology study from the Boyce Thompson Institute reports that ascaroside 18, a nematode pheromone, gives plants lasting protection against a broad range of pathogens.
- Dan Klessig says the treated plants did not show the growth-for-defense tradeoff of a full immune response, because ascr#18 tells the plant to get ready rather than to fight.
- In field work, foliar application reduced fungal disease severity and improved yield in corn and soybean, which the team offers as evidence the effect translates outside controlled conditions.
- Soaking seed in an ascr#18 solution was enough to prime plants for stronger defense later in development, without any application timed to the arrival of a pathogen.
Why it matters
- capability A priming effect installed at the seed stage would let a grower buy protection before the season starts, rather than reacting to a disease forecast inside a narrow spray window.
- constraint Without a severity percentage, a site count or a season count, nobody can put this next to an existing fungicide program on a cost-per-acre basis, which is the only comparison that decides a purchase.
- decision With 75 percent of the named leads holding co-founder status in Ascribe Bioscience, the burden of proof for anyone evaluating the product sits on independent field replication.
- precedent If priming works without a growth penalty, it strengthens the case for resistance-management products that never touch the pathogen, a category regulators and agronomists have mostly treated as secondary.
The broad-spectrum part of this story is older than the paper. The lab's earlier work already reported that recognition of ascr#18 gave plants a slightly heightened state of immune vigilance and raised resistance to bacterial, viral, fungal and nematode pathogens [7]. What the new work adds is a mechanism and a field demonstration [8][11], which are two different kinds of evidence and should be graded separately.
The mechanism is the more satisfying half. Priming, as Uwe Conrath of RWTH Aachen describes it, works at the chromatin level: defense genes are left more accessible to the transcriptional machinery, so they fire faster once infection arrives [8]. That is a coherent explanation for the economics Dan Klessig describes, in which a full immune response diverts energy from growth while ascr#18 treatment did not show that cost [1]. Worth reading precisely: not observing a growth penalty under the conditions tested is a weaker statement than the absence of one, and the account does not say which growth measurements were taken or for how long.
The field result is where an operator should slow down. Foliar application reduced fungal disease severity and improved yield in corn and soybean [11]. The announcement gives no magnitude for either effect, no number of trial sites, and no number of seasons [15]. Priming accelerates a response the plant would eventually mount anyway; whether a faster response holds up under the inoculum pressure that sends a grower to a fungicide in the first place is exactly what a severity number would answer, and there is not one here.
The seed soak is the genuinely interesting operational claim. Soaking seed in ascr#18 solution was sufficient to prime plants for enhanced defense later in development, unlike treatments that have to land shortly before or during an attack [9]. That moves the decision off the spray calendar and onto the seed invoice, which is a different budget line and a different logistics problem.
Three of the four named research leads, Klessig, Frank Schroeder and Murli Manohar, co-founded the BTI startup Ascribe Bioscience [5], or 75 percent of the named leadership [10]. That is ordinary in translational plant science and it is disclosed. It also means Manohar's emphasis on ease of use and affordability [13] is a company position rather than a measured cost, and that the framing figure of up to 40 percent of global food crops lost annually [2] belongs to the problem statement, not to this study's results.
My read: the chromatin priming mechanism is the durable contribution, and I would treat the corn and soybean field claim as provisional until severity numbers, plot counts and a season run by people without equity are on the table.
What to watch
- The Communications Biology paper's trial design: plot numbers, seasons, disease pressure, and the size of the yield gain in corn and soybean.
- An independent group with no Ascribe Bioscience equity testing whether seed-soak priming persists to harvest in field conditions.
- A registration pathway and a per-acre price, which would turn the affordability claim into something checkable.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence42
- Adoption
- Insufficient
- Hype gap+32
- Incentives78
- Confidence44
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Klessig said a full plant immune response carries a fitness cost because energy shifts from growth and development to fighting the pathogen, and that with ascr#18 treatment the team did not see that; instead ascr#18 signals plants to get ready, giving immune memory without the fitness cost.
- [2]
The report states that plant pathogens can have devastating effects on crop yields, with up to 40% of global food crops lost annually.
- [3]
A study published in Communications Biology by scientists at the Boyce Thompson Institute found that a previously unrecognized natural compound, the nematode pheromone ascaroside 18 (ascr#18), can provide lasting protection against a broad range of plant pathogens.
- [4]
The research was led by BTI professor emeritus Dan Klessig and professor Frank Schroeder with former BTI postdoc Murli Manohar, together with Uwe Conrath, professor at RWTH Aachen University in Germany.
- [5]
Klessig, Schroeder and Manohar are all co-founders of the BTI startup Ascribe Bioscience.
- [6]
Nematodes, which are ubiquitous in soil and include many plant and animal parasites, produce simple glycolipids called ascarosides.
- [7]
In the team's earlier studies on nematode-plant interactions, ascaroside 18 stood out for activating hallmarks of plant defense; recognition of ascr#18 granted plants a slightly heightened state of immune vigilance and increased their resistance to bacterial, viral, fungal and nematode pathogens.
- [8]
Conrath said ascr#18 primes the plant by making changes at the chromatin level that establish a long-lasting state of immune memory, increasing the accessibility of defense genes to the transcriptional machinery so they can be activated more rapidly when infection occurs.
- [9]
Simply soaking seeds in an ascr#18 solution was sufficient to prime plants for enhanced defense later in development, unlike treatments that must be applied shortly before or during pathogen attack.
- [10]
Three of the four named research leads, or 75 percent, are co-founders of Ascribe Bioscience.
- [11]
The team demonstrated translatability to the field, where foliar application of ascr#18 reduced fungal disease severity and improved yield in corn and soybean.
- [12]
Manohar said pathogens adapt and develop resistance to existing strategies, and that other products available today stimulate immune responses at the expense of growth and development.
ReportedInsufficientSource: Murli Manohar2 sources— create a free account to open themView cited source - [13]
Manohar emphasized the ease of use and affordability of ascr#18 for immune priming, calling it a simple compound with a very simple application process.
ReportedInsufficientSource: Murli Manohar2 sources— create a free account to open themView cited source - [14]
The team reports that immune priming via ascr#18 is effective in a wide variety of agriculturally important crops.
- [15]
The published account of the corn and soybean field results states no magnitude for the disease-severity reduction or the yield gain, no number of trial sites, and no number of seasons.
Sources
1 independent publisher whose own reporting we read for this story.
- phys.orgPrimed and ready to fight, a nematode pheromone arms plants to battle pathogens
1 article · August 27, 2026
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.